We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+13.67%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$760M
AUM Growth
+$340M
Cap. Flow
+$291M
Cap. Flow %
38.36%
Top 10 Hldgs %
28.91%
Holding
642
New
116
Increased
240
Reduced
29
Closed
257

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.76%
2 Communication Services 17.36%
3 Technology 11.92%
4 Financials 9.63%
5 Industrials 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAB icon
201
Wabtec
WAB
$49.4B
$262K 0.03%
3,220
+506
+19% +$38.7K
TSCO icon
202
Tractor Supply
TSCO
$15.8B
$261K 0.03%
17,500
+2,750
+19% +$35.3K
ILMN icon
203
Illumina
ILMN
$31B
$260K 0.03%
1,223
+192
+19% +$39.5K
LLY icon
204
Eli Lilly
LLY
$1.03T
$260K 0.03%
3,080
+484
+19% +$41.2K
COO icon
205
Cooper Companies
COO
$14.2B
$259K 0.03%
4,760
+748
+19% +$43.7K
SNA icon
206
Snap-on
SNA
$21.2B
$256K 0.03%
1,470
+231
+19% +$37.3K
UGI icon
207
UGI
UGI
$7.76B
$253K 0.03%
5,390
+1,024
+23% +$48.9K
EW icon
208
Edwards Lifesciences
EW
$50B
$252K 0.03%
6,720
+1,056
+19% +$38.8K
GILD icon
209
Gilead Sciences
GILD
$163B
$250K 0.03%
3,500
+550
+19% +$41.8K
QCOM icon
210
Qualcomm
QCOM
$160B
$250K 0.03%
3,920
+616
+19% +$37.4K
COTY icon
211
Coty
COTY
$2.37B
$249K 0.03%
12,530
+1,969
+19% +$33.6K
COL
212
DELISTED
Rockwell Collins
COL
$246K 0.03%
1,820
+1,702
+1,442% +$228K
AMGN icon
213
Amgen
AMGN
$209B
$243K 0.03%
1,400
+220
+19% +$38.9K
ZBH icon
214
Zimmer Biomet
ZBH
$18.4B
$236K 0.03%
2,019
+317
+19% +$35.8K
PNR icon
215
Pentair
PNR
$10.6B
$232K 0.03%
4,899
+770
+19% +$36K
BMY icon
216
Bristol-Myers Squibb
BMY
$132B
$231K 0.03%
3,780
+594
+19% +$37.2K
TWX
217
DELISTED
Time Warner Inc
TWX
$230K 0.03%
2,520
+396
+19% +$37.4K
MON
218
DELISTED
Monsanto Co
MON
$228K 0.03%
1,960
+308
+19% +$36.6K
HAS icon
219
Hasbro
HAS
$13.4B
$209K 0.03%
2,310
+363
+19% +$34K
ALXN
220
DELISTED
Alexion Pharmaceuticals
ALXN
$200K 0.03%
1,680
+264
+19% +$32.2K
M icon
221
Macy's
M
$6.56B
$197K 0.03%
7,840
+1,527
+24% +$33.5K
PANW icon
222
Palo Alto Networks
PANW
$265B
$192K 0.03%
7,980
+1,254
+19% +$30.5K
TAP icon
223
Molson Coors Class B
TAP
$7.79B
$189K 0.02%
2,310
+540
+31% +$43.7K
JQC icon
224
Nuveen Credit Strategies Income Fund
JQC
$705M
$185K 0.02%
22,572
+8,212
+57% +$67.9K
AYI icon
225
Acuity Brands
AYI
$10.1B
$184K 0.02%
1,050
+165
+19% +$27.5K

Similar funds

Penserra Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Penserra Capital Management held 642 positions worth $760M, up 81% from $420M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Penserra Capital Management deployed $291M of net new capital in Q4 2017, opening 116 new positions and adding to 240 existing holdings. Its largest new stake was Atlassian: 180,482 shares worth $8.21M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 36% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Lam Research, an estimated $3.19M trimmed.

  • Penserra Capital Management's largest Q4 2017 buy was Atlassian: 180,482 shares worth $8.21M.
  • Penserra Capital Management added most to Thor Industries in Q4 2017, an estimated $8.44M increase.
  • Penserra Capital Management's biggest Q4 2017 reduction was Lam Research, cutting an estimated $3.19M.
  • Penserra Capital Management fully exited HSN, Inc. in Q4 2017, selling an estimated $3.13M.
  • Penserra Capital Management's ten largest holdings make up 29% of its $760M portfolio in Q4 2017.
  • Penserra Capital Management opened 116 new positions and closed 257 in Q4 2017.
  • Penserra Capital Management's portfolio value rose 81% quarter-over-quarter to $760M.

Based on Penserra Capital Management's 13F filing for Q4 2017, filed 7 Feb 2018.